Magoulas George E, Kostopoulou Ourania N, Garnelis Thomas, Athanassopoulos Constantinos M, Kournoutou Georgia G, Leotsinidis Michael, Dinos George P, Papaioannou Dionissios, Kalpaxis Dimitrios L
Laboratory of Synthetic Organic Chemistry, Department of Chemistry, University of Patras, GR-26504 Patras, Greece.
Department of Biochemistry, School of Medicine, University of Patras, GR-26504 Patras, Greece.
Bioorg Med Chem. 2015 Jul 1;23(13):3163-74. doi: 10.1016/j.bmc.2015.04.069. Epub 2015 May 1.
A series of chloramphenicol (CAM) amides with polyamines (PAs), suitable for structure-activity relationship studies, were synthesized either by direct attachment of the PA chain on the 2-aminopropane-1,3-diol backbone of CAM, previously oxidized selectively at its primary hydroxyl group, or from chloramphenicol base (CLB) through acylation with succinic or phthalic anhydride and finally coupling with a PA. Conjugates 4 and 5, in which the CLB moiety was attached on N4 and N1 positions, respectively, of the N(8),N(8)-dibenzylated spermidine through the succinate linker, were the most potent antibacterial agents. Both conjugates were internalized into Escherichia coli cells by using the spermidine-preferential uptake system and caused decrease in protein and polyamine content of the cells. Noteworthy, conjugate 4 displayed comparable activity to CAM in MRSA or wild-type strains of Staphylococcus aureus and Escherichia coli, but superior activity in E. coli strains possessing ribosomal mutations or expressing the CAM acetyltransferase (cat) gene. Lead compounds, and in particular conjugate 4, have been therefore discovered during the course of the present work with clinical potential.
合成了一系列适合进行构效关系研究的含多胺(PA)的氯霉素(CAM)酰胺,方法是将PA链直接连接到CAM的2-氨基丙烷-1,3-二醇主链上(该主链的伯羟基已预先选择性氧化),或者从氯霉素碱(CLB)开始,先与琥珀酸酐或邻苯二甲酸酐进行酰化反应,最后与PA偶联。共轭物4和5中,CLB部分分别通过琥珀酸酯连接基连接到N(8),N(8)-二苄基亚精胺的N4和N1位置,它们是最有效的抗菌剂。这两种共轭物都通过亚精胺优先摄取系统内化到大肠杆菌细胞中,并导致细胞内蛋白质和多胺含量降低。值得注意的是,共轭物4在耐甲氧西林金黄色葡萄球菌(MRSA)或金黄色葡萄球菌和大肠杆菌的野生型菌株中表现出与CAM相当的活性,但在具有核糖体突变或表达氯霉素乙酰转移酶(cat)基因的大肠杆菌菌株中表现出更强的活性。因此,在本研究过程中发现了具有临床潜力的先导化合物,尤其是共轭物4。